-
Something wrong with this record ?
Myasthenia gravis, Castleman disease, pemphigus, and anti-phospholipid syndrome
M. Jakubíková, J. Piťha, J. Latta, E. Ehler, J. Schutzner,
Language English Country United States
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
23386221
DOI
10.1002/mus.23657
Knihovny.cz E-resources
- MeSH
- Antiphospholipid Syndrome complications pathology MeSH
- Blepharoptosis etiology MeSH
- Stroke etiology MeSH
- Diplopia etiology MeSH
- Adult MeSH
- Fatal Outcome MeSH
- Castleman Disease complications pathology MeSH
- Humans MeSH
- Myasthenia Gravis complications pathology MeSH
- Abdominal Neoplasms pathology MeSH
- Neurologic Examination MeSH
- Pemphigus complications pathology MeSH
- Tomography, X-Ray Computed MeSH
- Muscle Weakness etiology MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
INTRODUCTION: Myasthenia gravis is an autoimmune disease marked by neuromuscular transmission failure at the neuromuscular junction. Castleman disease is a rare lymphoproliferative disease characterized by non-cancerous angiofolicular hyperplasia of lymphatic tissue. METHODS AND RESULTS: We describe a young man with rapid, successive manifestations of myasthenia gravis, a solitary form of Castleman disease, pemphigus vulgaris, and anti-phospholipid syndrome, which resulted in 2 ischemic cerebrovascular events that caused a severe central neurological deficit. DISCUSSION: We were unable to find a similar case in the literature, but we hypothesize that the temporal concidence of these clinical entities may be related to a common immunological pathway, such as B-cell activation. Therefore, we treated the patient with an immunosuppressant and anticoagulant treatment, as well as rituximab, a monoclonal antibody therapy against CD20+.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13023974
- 003
- CZ-PrNML
- 005
- 20130710105000.0
- 007
- ta
- 008
- 130703s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mus.23657 $2 doi
- 035 __
- $a (PubMed)23386221
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jakubíková, Michala $u Department of Neurology and Center of Clinical Neuroscience, Charles University Prague, First Faculty of Medicine and General University Hospital, Prague Kateřinská 30, 128 01 Praha 2, Czech Republic. michala.jakubikova@vfn.cz
- 245 10
- $a Myasthenia gravis, Castleman disease, pemphigus, and anti-phospholipid syndrome / $c M. Jakubíková, J. Piťha, J. Latta, E. Ehler, J. Schutzner,
- 520 9_
- $a INTRODUCTION: Myasthenia gravis is an autoimmune disease marked by neuromuscular transmission failure at the neuromuscular junction. Castleman disease is a rare lymphoproliferative disease characterized by non-cancerous angiofolicular hyperplasia of lymphatic tissue. METHODS AND RESULTS: We describe a young man with rapid, successive manifestations of myasthenia gravis, a solitary form of Castleman disease, pemphigus vulgaris, and anti-phospholipid syndrome, which resulted in 2 ischemic cerebrovascular events that caused a severe central neurological deficit. DISCUSSION: We were unable to find a similar case in the literature, but we hypothesize that the temporal concidence of these clinical entities may be related to a common immunological pathway, such as B-cell activation. Therefore, we treated the patient with an immunosuppressant and anticoagulant treatment, as well as rituximab, a monoclonal antibody therapy against CD20+.
- 650 _2
- $a nádory břicha $x patologie $7 D000008
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a antifosfolipidový syndrom $x komplikace $x patologie $7 D016736
- 650 _2
- $a blefaroptóza $x etiologie $7 D001763
- 650 _2
- $a diplopie $x etiologie $7 D004172
- 650 _2
- $a fatální výsledek $7 D017809
- 650 _2
- $a hyperplazie velkých lymfatických uzlin $x komplikace $x patologie $7 D005871
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a svalová slabost $x etiologie $7 D018908
- 650 _2
- $a myasthenia gravis $x komplikace $x patologie $7 D009157
- 650 _2
- $a neurologické vyšetření $7 D009460
- 650 _2
- $a pemfigus $x komplikace $x patologie $7 D010392
- 650 _2
- $a cévní mozková příhoda $x etiologie $7 D020521
- 650 _2
- $a počítačová rentgenová tomografie $7 D014057
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Piťha, Jiří $u -
- 700 1_
- $a Latta, Jan $u -
- 700 1_
- $a Ehler, Edvard $u -
- 700 1_
- $a Schutzner, Jan $u -
- 773 0_
- $w MED00003426 $t Muscle & nerve $x 1097-4598 $g Roč. 47, č. 3 (2013), s. 447-51
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23386221 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130710105423 $b ABA008
- 999 __
- $a ok $b bmc $g 987654 $s 822354
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 47 $c 3 $d 447-51 $i 1097-4598 $m Muscle and nerve $n Muscle Nerve $x MED00003426
- LZP __
- $a Pubmed-20130703
